Silexion Therapeutics Corp - Warrants(14/08/2029)
SLXNW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.02K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5,018.00 |
|---|---|
| Enterprise Value | $-813,982.00 |
| Earnings per Share | $-89.6 |
| Beta | -0.27 |
| Outstanding Shares | 687,353 |
Return
| Return on Equity | 11668.18% |
|---|---|
| Return on Assets | 120.91% |
| Return on Invested Capital | -1764.00% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.17 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | -1.91 |
| Debt to Equity | 32.05 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-21.20
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-9.10
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 26,6830% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 352.21%▲ 176.22% |
|---|---|
| Total Invested | $98,674▲ 59.23% |
| Investors Holding | 210% |